Close Menu

NEW YORK (GenomeWeb) – In a filing with the US Securities and Exchange Commission this week, Foundation Medicine said it is planning to expand its offices in Cambridge, Massachusetts, and will take over a lease for approximately 53,455 square feet of office and laboratory space currently occupied by Bluebird Bio. The company has also extended its lease through April 30, 2024. In its SEC filing, Foundation noted that the monthly rent on the space will start at $418,308.53 in May 2017, and will go up incrementally until it reaches $833,675.37 per month in April 2024.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.